Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 244 clinical trials
None
  • 0 views
  • 18 Aug, 2021
  • 1 location
None
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis

Primary Objective: Assess change in neuronal architecture following long term treatment with dupilumab in skin biopsies from atopic dermatitis (AD) participants with chronic

eczema
Accepts healthy volunteers
skin biopsy
dupilumab
  • 0 views
  • 05 Nov, 2021
  • 3 locations
None
Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis

patients with moderate to severe atopic dermatitis (AD) treated with dupilumab Secondary Objectives: Evaluate changes in skin barrier function with TEWL assessed after STS in

dupilumab
Accepts healthy volunteers
erythema
  • 0 views
  • 05 Nov, 2021
  • 3 locations
None
NMF-CsA-Dupi Trial

The goal of this study is to investigate whether stratification of children with atopic dermatitis on the NMF biomarkers results in an improvement of effectiveness and efficiency in the use of

corticosteroids
dupilumab
topical agents
high potency
eczema
  • 0 views
  • 26 Aug, 2021
  • 1 location
None
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

This is a Phase II, randomized, double-blind, placebo-controlled study in subjects with moderate to severe atopic dermatitis.

  • 1 views
  • 12 Sep, 2021
  • 1 location
None
Effect of Moisturizing Creams on Skin Barrier Function

This study is a randomized, double-blind, placebo-controlled bilateral study on the effect of moisturizing creams on skin barrier function. The hypothesis is that a new active emulsion has a better influence on skin barrier function comapred to its placebo.

dry skin
atopy
  • 57 views
  • 07 Nov, 2020
  • 1 location
None
Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema

inhibiting the IL-4 and IL-13 pathway by targeting the IL-4-receptor, has been approved for the treatment of moderate-to-severe atopic dermatitis (AD). Since there is an overlap between AD and NE with both

  • 0 views
  • 29 Mar, 2021
  • 1 location
None
Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids

Dupilumab has recently demonstrated high efficacy and good safety profile in the treatment of moderate-to-severe atopic dermatitis. There is a crucial need of developing new treatment options in

  • 0 views
  • 12 Sep, 2021
  • 3 locations
None
A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China

This study will evaluate the efficacy and safety of CBP-201 in Chinese adult subjects with moderate to severe atopic dermatitis.

  • 0 views
  • 29 Sep, 2021
  • 27 locations
None
A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

The purpose of this study is to assess the effect of B. infantis (EVC001) versus placebo supplementation, in healthy breastfed infants at risk of developing atopic dermatitis (AD), on cumulative

Accepts healthy volunteers
  • 2 views
  • 13 Nov, 2021
  • 1 location